Votrient 200 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB26FWFZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,478
Award facts
- Contract value 100% obligated
- $11,477.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,477.96 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Votrient 200 mg tablets (120 count). This competitive award, with no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and extending through December 2026. The broader contract vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract serves customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's Pharmaceutical Prime Vendor program supporting defense medical supply chains.
Quick answers
Who was awarded contract SPE2DB26FWFZY?
SPE2DB26FWFZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FWFZY worth?
The government has obligated $11,478 on SPE2DB26FWFZY.
Is contract SPE2DB26FWFZY an order under another contract?
Yes. SPE2DB26FWFZY is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWFZY competed?
The extent of competition for SPE2DB26FWFZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award